Project Grant R01NS140001

Award Date 12/15/24
Completion Date 11/30/29
Dollars Obligated $618K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This Project Grant award of $231,000.00 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, supports research to develop and assess culturally-tailored approaches to improve equity in palliative care for Parkinson's disease, Lewy body dementia, and related disorders within Black and Hispanic communities. The key objectives are to: 1) strengthen...
The University of Pittsburgh is the prime recipient of a $725,595 Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The 5-year project, titled "BRAIN CHEC-AC (BRAIN AND COGNITIVE HEALTH EQUITY CAMPAIGN FOR ALLEGHENY COUNTY)", aims to address disparities in early detection and diagnosis of Alzheimer's and related...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, is funding a $423,500 research project at the University of Rochester to investigate racial and ethnic disparities in non-motor symptoms experienced by individuals with Parkinson's disease. The study aims to compare the occurrence, treatment, and burden of non-motor symptoms...
The University of California, Irvine was awarded a $235,795 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The goal of this 3-year project is to generate socially- and culturally-aligned approaches for engaging Black communities in Southern California in Alzheimer's disease and related dementias (ADRD) research and clinical trials....
This $187,500 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will fund research conducted by Xavier University of Louisiana. The research aims to examine the relationship between allostatic load (an indicator of physiological dysregulation) and cognitive function, and how this association may be impacted by neighborhood...
This $4.5 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866). The University of Michigan will examine racial inequities in neurological conditions like vascular contributions to cognitive impairment and dementia (VCID) and stroke. Leveraging the Reasons for Geographic and Racial Differences in Stroke study cohort of over 30,000 adults, the research aims to determine...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $232,336 to support the ENLIGHTEN (Engaging Leaders in Global and Local Health Equity in Neurology) training program at the University of California, San Francisco (UCSF). The goal of ENLIGHTEN is to prepare clinician researchers and PhD scientists to become leaders in neurologic...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a 5-year, $672,437 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Northwestern University. The grant, titled "Advancing Community Connections and Calculating Risk to Optimize Stroke Survivorship (ACROSS)," aims to decrease stroke disparities among Black, Latino/a/x, and socioeconomically disadvantaged populations by: Increasing stroke...
This Project Grant award of $238,888 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program is aimed at developing and implementing a "neurologic-informed care" (NIC) model to improve health equity among individuals with traumatic brain injuries (TBI) experiencing homelessness. The key objectives of this 3-year project are to: 1) assess client and...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $221,120 to the University of Texas Health Science Center at Houston (UTHealth) to investigate the potential of adult central nervous system endothelial cells to guide neural progenitor cell migration and enhance neurovascular communication. The research aims to boost...

This federal Project Grant award of $617,687 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program aims to build infrastructure for community-engaged research interventions focused on three neurological conditions affecting brain health: stroke, vascular cognitive impairment and dementia, and Parkinson's disease.

The key objectives are to establish community-level and patient-level oversight, identify multilevel barriers to research inclusion for Black and Hispanic patients, and design and pilot a brain equity curriculum for bidirectional community and academic learning. Upon completion, the project will provide the partnerships, knowledge, and infrastructure needed to design rigorous clinical trials with equitable representation from communities disproportionately impacted by neurological diseases. The award will be performed by the University of Texas Health Science Center at Houston, leveraging their expertise in biomedical research, clinical trials, and translational science.

Generated 6/10/25, 3:46 AM